Japan’s Takeda clinches $62 billion deal to buy drugmaker Shire

Japan’s Takeda clinches $62 billion deal to buy drugmaker Shire

Takeda Pharmaceutical Company Limited(OTC:TKPYY、TKPHF、TYO:4502、FSE:4502) agreed to buy London-listed Shire plc (NASDAQ:SHPG) for 45.3 billion pounds ($61.50 billion) on Tuesday after the Japenese company raised the amount of cash in its offer to secure a recommendation. The deal — assuming it wins the backing of shareholders — will be the largest overseas acquisition by a Japanese company and propel Takeda, led by Frenchman Christophe Weber, into the top ranks of global drugmakers. The tie-up is one…

Read More